Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M2IS
|
||||
Former ID |
DIB012528
|
||||
Drug Name |
Hebergel
|
||||
Synonyms |
Interferon alpha 2b gel (viral infection), CIGB
|
||||
Indication | Viral infections [ICD9: 054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053; ICD10:B01, B02, A60, B00, B27, G05.1, P35.2] | Phase 3 | [529448] | ||
Company |
Center for Genetic Engineering and Biotechnology
|
||||
Target and Pathway | |||||
Target(s) | Interferon alpha 2 ligand | Target Info | Modulator | [527899] | |
KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
Regulation of autophagy | |||||
PI3K-Akt signaling pathway | |||||
Toll-like receptor signaling pathway | |||||
RIG-I-like receptor signaling pathway | |||||
Cytosolic DNA-sensing pathway | |||||
Jak-STAT signaling pathway | |||||
Natural killer cell mediated cytotoxicity | |||||
Tuberculosis | |||||
Hepatitis C | |||||
Hepatitis B | |||||
Measles | |||||
Influenza A | |||||
Herpes simplex infection | |||||
Autoimmune thyroid disease | |||||
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Downstream signaling in naï | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.